Zenflow Announces $24 Million Financing Round to Fund FDA Filing & Commercial Preparation SOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Zenflow, Inc., a medical device company developing a minimally invasive treatment for urinary obstruction caused by enlarged prostate,...

Zenflow Launches Pivotal Clinical Trial of Minimally Invasive Spring® Treatment for Enlarged Prostate Symptoms SOUTH SAN FRANCISCO, Calif., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Zenflow, Inc., a medical device company developing a minimally invasive treatment for enlarged prostate, or benign prostatic...

Zenflow Announces $24 Million Financing Round; Appoints Susan Stimson as President SOUTH SAN FRANCISCO, Calif., June 02, 2021 (GLOBE NEWSWIRE) -- Zenflow, Inc., a medical device company developing a minimally invasive treatment for urinary obstruction caused by enlarged prostate,...

Zenflow Raises $31.4M in Series A Funding SAN FRANCISCO, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Zenflow, Inc., a privately held medical device company based in the San Francisco Bay Area, today announced the closing of a $31.4 million Series A...